Current Issue
November 2024, Volume 43, Issue 7
The November 2024 issue (43:7) features a commentary on re-examining mandatory drug testing in Australian prisons.
Research from Australia covered a wide range of topics, including: police-issued barring notices in Western Australia; the prevalence and magnitude of price promotions in online alcohol retail outlets; tobacco retail availability and smoking; E-cigarette use in pregnancy; enhancing the SUSTAINable uptake of evidence to minimise harms from alcohol and other drugs in New South Wales; client and stakeholder perceptions of a novel, nurse practitioner-led alcohol and other drug ambulatory withdrawal service; understanding cultural inclusion in alcohol and other drug services in New South Wales and assessing the acceptability of a cultural inclusion audit; screening and early intervention for substance use during pregnancy; clinical effectiveness of pharmacist administration of long-acting injectable buprenorphine; changes in Australians' attitudes towards supervised injecting facilities; perceived barriers to help-seeking for people who use crystal methamphetamine; substance use among trans and gender diverse young people; women's challenges in anabolic steroid acquisition and the place of drug checking interventions; the health effects of non-prescribed anabolic–androgenic steroid use; situating the risks of insulin within the image and performance enhancing drug community; patterns of substance use recovery following residential treatment; stigma by association among alcohol and other drug and harm reduction workers: Implications for workplace outcomes; clinical profiles of people enrolling in alcohol and other drug treatment; novel harm reduction measures at music festivals in Australia; the impact of the COVID-19 pandemic on calls to an alcohol and drug helpline in Victoria for alcohol, methamphetamine and cannabis use concerns; and emergence of deaths due to nitazene toxicity in Australia.
One paper from New Zealand had a qualitative analysis on young people's experiences of addiction to nicotine vaping products.
Internation research focused on: how agent-based modelling can provide new insights into the impact of minimum unit pricing in Scotland; trends in alcohol-attributable morbidity and mortality in Germany; characteristics of consumers of alcohol-free and low-alcohol drinks in Great Britain; the societal value of health lost to alcohol use in India compared to excise taxes on alcohol sales; reasons pregnant people use cannabis to self-treat health conditions during pregnancy; geographic clustering of cannabis stores in Canadian cities; whether the THC concentration predict the number of patients with cannabis-related diagnoses; whether maternal education moderates the relationship between adolescent cannabis use and mental health in early adulthood; characterising individuals with a substance use disorder accessing hospital-based addiction care; assessment of treatment retention rates and predictors of retention on opioid agonist treatment among adolescents; healthcare utilisation and associated costs for methadone versus buprenorphine recipients; relationship between patient activation and utilisation of health care and harm reduction services among people who inject drugs in Baltimore, Maryland; preferences for field-based post-overdose interventions; the associations of supervised consumption services with the rates of opioid-related mortality and morbidity outcomes at the public health unit level in Ontario (Canada); characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada; mapping a psychosocial syndemic among methamphetamine-using sexual minority men living with HIV; associations between US male sex workers' internet advertising characteristics and advertising chemsex to prospective clients; an empirically based typology of temporary alcohol abstinence challenge participants using latent class analysis; psychometric evaluation of the Dutch version of the patient-reported experience measure for addiction treatment (PREMAT-NL); examination of drinking as a mediator of the relationship between alcohol-related social media content and adherence to COVID-19 recommendations among college students; determinants of psychological distress during the COVID-19 pandemic among people who use drugs in Montreal, Canada; and trends in substance use disorder mortality in the United States and worldwide.
Cannabis legalisation and its impact on access, use and public perceptions
Follow Drug and Alcohol Review on Twitter
What's new on Early View?
The latest COVID-19 research is available online.
Review
Associations of parenting styles with substance use in the offspring—A systematic review and meta-analysis
Martin Pinquart, Jana Lauk
13 October 2024 | DOI: https://doi.org/10.1111/dar.13961
Original Papers
Drinking practices: The variation of drinking events across intersections of sex, age and household income
Petra S. Meier, John Holmes, Abigail Stevely, Jennifer E. Boyd, Monica Hernández Alava, Iain Hardie, Alan Warde, Alessandro Sasso
13 November 2024 | DOI: https://doi.org/10.1111/dar.13975
Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-scheduling
Jordan J. Negrine, Cheneal Puljević, Jason Ferris, Paul Liknaitzky, Christopher Perlman, Timothy Piatkowski
5 November 2024 | DOI: https://doi.org/10.1111/dar.13973
New immersive alcohol marketing and commerce in metaverse environments
Taisia Huckle, Kristen Mummert, Antonia Lyons, Tim McCreanor, Georgia McLellan, Helen Moewaka Barnes
4 November 2024 | DOI: https://doi.org/10.1111/dar.13967
University-based academic programs in addiction studies in the regions of Australia and Aotearoa New Zealand: An overview
Amalie Lososová, Peter Adams, Michal Miovský
3 November 2024 | DOI: https://doi.org/10.1111/dar.13970
Public and professional stakeholders’ perceptions of alcohol advertising and availability policies: A qualitative study
Elena D. Dimova, Niamh K. Shortt, Matt Smith, Richard J. Mitchell, Peter Lekkas, Jamie R. Pearce, Tom L. Clemens, Carol Emslie
28 October 2024 | DOI: https://doi.org/10.1111/dar.13972
A netnographic study of anabolic-androgenic steroid initiation videos on YouTube
Matthew J. Gill, Timothy Piatkowski, Matthew Dunn
27 October 2024 | DOI: https://doi.org/10.1111/dar.13969
Acceptability and quality of the ‘Grog Survey App’ brief intervention: Helping Aboriginal Australians reflect on their drinking using a digital health tool
KS Kylie Lee, James H. Conigrave, Elizabeth Dale, Katherine M. Conigrave, Monika Dzidowska, Taleah Reynolds, Scott Wilson, Jimmy Perry, Danielle Manton, Alex Lee, Noel Hayman, Catherine Zheng, Michelle Fitts, Dan Wilson, Angela Dawson
24 October 2024 | DOI: https://doi.org/10.1111/dar.13964
New South Wales alcohol and other drug service providers' perceptions of the relative importance of client variables for determining treatment need
Briony Larance, Isabella Ingram, Chloe Haynes, Lexi Buckfield, Choon Wee Melvin Goh, Peter J. Kelly
21 October 2024 | DOI: https://doi.org/10.1111/dar.13952
Consuming ‘God Juice’: Using ‘ethnopharmacological-connoisseurship’ to situate trenbolone use and knowledge among image and performance enhancing drug communities
Timothy Piatkowski, Nick Gibbs, David Neumann, Matthew Dunn
21 October 2024 | DOI: https://doi.org/10.1111/dar.13965
Examining the association between psychological resilience and chronic versus discrete stressors among individuals who use opioids in Baltimore, Maryland
Laura Nicole Sisson, Catherine Tomko, Saba Rouhani, Susan G. Sherman
17 October 2024 | DOI: https://doi.org/10.1111/dar.13959
The impact of Scotland's minimum unit pricing for alcohol policy on people accessing services for alcohol dependence: A difference-in-difference structured interview study
Penny Buykx, Andy Perkins, Jane Hughes, Wulf Livingston, Jennifer Boyd, Parvati Perman-Howe, Allan Johnston, Trevor McCarthy, Alex McLean, Alex Wright, Simon Little, John Holmes
16 October 2024 | DOI: https://doi.org/10.1111/dar.13960
Routine outcome monitoring and feedback in alcohol and other drug treatment: A qualitative study of client perspectives on implementation
Nina Pocuca, Calvert Tisdale, Gabrielle Campbell, Alison K. Beck, Rhiannon Ellem, Catherine A. Quinn, Peter J. Kelly, Briony Larance, Amanda L. Baker, Jason P. Connor, John Marsden, Gary C. K. Chan, Luke Connelly, Sabrina Lenzen, Michael Farrell, Leanne Hides
14 October 2024 | DOI: https://doi.org/10.1111/dar.13962
Integration of a facilitated access pathway for contraception into alcohol and other drug treatment services: A cohort study comparing metropolitan and regional settings
Kelly A. McNamara, Bridin Murnion, Nicholas Lintzeris, Vicki Chase, Emma Black, Annie Malcolm, Lucy Harvey Dodds, Natasha Nassar, Kirsten I. Black
8 October 2024 | DOI: https://doi.org/10.1111/dar.13957
The differential effects of parent-targeted alcohol harm-reduction campaigns with varying executional styles
Leon Booth, Tahnee McCausland, James Stevens-Cutler, Keira Bury, Julia Stafford, Simone Pettigrew
7 October 2024 | DOI: https://doi.org/10.1111/dar.13958
Provider costs of treating opioid dependence with extended-release buprenorphine in Australia
Stella Settumba, Jeyran Shahbazi, Marianne Byrne, Louisa Degenhardt, Jason Grebely, Briony Larance, Suzanne Nielsen, Nicholas Lintzeris, Robert Ali, Craig Rodgers, Alison Blazey, Robert Weiss, Adrian Dunlop, Michael McDonough, Jon Cook, Michael Farrell
6 October 2024 | DOI: https://doi.org/10.1111/dar.13956
Vaping to quit smoking: Qualitative study of people receiving opioid agonist treatment
Kypros Kypri, Emma Austin, Melissa Jackson, Kirsten Wright, Amanda Shui, Andrew Li, Vinogi Sathasivam, Billie Bonevski, Adrian J. Dunlop
4 October 2024 | DOI: https://doi.org/10.1111/dar.13953
Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study
Perrine Roux, Aissatou Faye, Luis Sagaon-Teyssier, Cécile Donadille, Laélia Briand Madrid, Maria Patrizia Carrieri, Gwenaelle Maradan, Marie Jauffret-Roustide, Laurence Lalanne, Marc Auriacombe, the COSINUS study group
1 October 2024 | DOI: https://doi.org/10.1111/dar.13955
The extent and diversity of harm from the drinking of unknown others in Australia: An analysis of data from during the COVID-19 pandemic
Bree Willoughby, Robin Room, Heng Jiang, Sandra Kuntsche, Dan Anderson-Luxford, Anne-Marie Laslett
1 October 2024 | DOI: https://doi.org/10.1111/dar.13951
Representations of ‘risky’ drinking during pregnancy on Mumsnet: A discourse analysis
Lisa Schölin, Rachel Arkell
19 September 2024 | DOI: https://doi.org/10.1111/dar.13948
The acceptability of alcohol screening and brief intervention for older adults in community venues
Jennifer Seddon, Beth Bareham, Eileen Kaner, Barbara Hanratty, Sarah Wadd
16 September 2024 | DOI: https://doi.org/10.1111/dar.13949
Utilising paired measurements of phosphatidylethanol to monitor early success in alcohol abstinence
Daniel White, Sam Salman, David A. Joyce
16 September 2024 | DOI: https://doi.org/10.1111/dar.13947
Characteristics of drug-related deaths where individuals are found submerged in a bath or hot tub in the United Kingdom, 1997–2023
Emmert Roberts, Caroline Copeland, Shane Darke, Michael Farrell
10 September 2024 | DOI: https://doi.org/10.1111/dar.13950
Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)-related death in Australia, 2001–2023
Shane Darke, Johan Duflou, Agata Chrzanowska, Michael Farrell, Julia Lappin, Amy Peacock
5 September 2024 | DOI: https://doi.org/10.1111/dar.13940
Assessing the impact of stricter drink driving policy on alcohol consumption in a population of Hanoi, Vietnam using wastewater analysis
Thanh X. Bui, Hieu K. T. Ngo, Giang T. Vu, Qiuda Zheng, Dat M. Nguyen, Tran Thi Thanh Hue, Vu Ngan Binh, Nguyen Thi Kieu Anh, Phong K. Thai
23 August 2024 | DOI: https://doi.org/10.1111/dar.13929
Brief Report
Childhood traumatic experiences and vaping among Australian adolescents: A prospective investigation
Amy-Leigh Rowe, Siobhan M. O'Dean, Katrina E. Champion, Emma L. Barrett, Lucinda Grummitt, Katherine L. Mills, Maree Teesson, Nicola C. Newton, Lauren A. Gardner
11 November 2024 | DOI: https://doi.org/10.1111/dar.13974
Case Report
A case of severe and prolonged γ-hydroxybutyrate (GHB) withdrawal syndrome successfully managed with a slow benzodiazepine and baclofen taper
Rachit Gupta, Greta Moon, Yvonne Bonomo, Adam Pastor
17 July 2024 | DOI: https://doi.org/10.1111/dar.13911
Commentaries
How can the benefits of dietetic care be integrated into the treatment of patients undergoing alcohol withdrawal?
Cameron McLean, Linda Tapsell, Sara Grafenauer, Anne-Therese McMahon
13 October 2024 | DOI: https://doi.org/10.1111/dar.13963
Australia needs to better regulate alcohol marketing in films
Emmanuel Kuntsche, Paula O'Brien, Dan Anderson-Luxford, Maree Patsouras, Benjamin C. Riordan
3 September 2024 | DOI: https://doi.org/10.1111/dar.13938
Co-creating and implementing a novel pre-conference event to promote equity and inclusivity among academic researchers and people who use drugs
M. J. Stowe, Louise Hansford, Rachel Halford, Jason Wallace, Lise Lafferty
27 May 2024 | DOI: https://doi.org/10.1111/dar.13882
Letter to the Editor
Integrating youth-specific services in substance use disorder treatment: Insights from Taiwan
Hsin-Hung Chen, Lien-Chung Wei
30 September 2024 | DOI: htps://doi.org/10.1111/dar.13954
Obituary
Dr James Rankin, a man ahead of his time
Margaret Hamilton, Alex Wodak
30 October 2024 | DOI: https://doi.org/10.1111/dar.13966
Call for Papers
This Special Section aims to bring together contributions that leverage the latest advancement in AI to solve substance use and addiction-related problems (including gambling and other behavioural addictions). We prefer studies that build upon deep neural networks, the algorithms that underly all the recent breakthroughs in AI (such as most modern generative AI models including ChatGPT and DALL-E), but we would also consider studies that are based on traditional machine learning methods such as random forest.
If you have any queries about this Special Section, please contact the This email address is being protected from spambots. You need JavaScript enabled to view it..
This Special Section aims to bring together key emerging evidence on NoLos within and across research groups globally. Specifically, we welcome papers with empirical data from any country/region on:
- Data that characterises the emergence of NoLo products, product availability and accessibility, and market characteristics;
- Data reporting/analysing the marketing and advertising of NoLos [e.g., analysing strategies used by industries (alcohol and others) to promote the consumption of NoLos, studies on how NoLo marketing impacts use outcomes];
- Attitudes and action of teenagers below the legal drinking age and of teenagers’ parents concerning underage teenagers’ consumption of NoLo beverages with alcohol brands and packaging,
- Data reporting and exploring patterns of purchase and consumption and links with social, commercial and political determinants of health (tactics used by for-profit industries), and the drivers of purchase and consumption among particular population groups (young people, people who are pregnant; abstainers/people seeking to reduce their ethanol intake) with implications for harm/benefit and policy.
If you have any queries about this Special Section, please contact the This email address is being protected from spambots. You need JavaScript enabled to view it..
Drug and Alcohol Review - Clinician's Corner
Best way forward for services seeking to reduce substance related harm among young people
Although almost 40% of all people receiving alcohol and other drug treatment in Australia are aged less than 30 years [1], there is a substantial lack of understanding of how to support and care for young people with alcohol and other drug problems, with the number of adolescent treatment outcome studies overshadowed by those devoted to adults [2]. Few rigorous evaluations of interventions and best-practice frameworks exist, and research into how best to engage young people effectively and sensitively is limited [2]. We do know, however, that young people use drugs differently than adults and have distinct treatment requirements [3]. As such, adult alcohol and other drug interventions should not be transplanted into a youth service and expected to work [4].
Although many health services have moved to youth-centred service models to improve engagement with young people [5], implementing youth-friendly healthcare within adult-orientated health spaces remains a challenge. Hospital-based services are consistently found to be less effective in engaging young people [4] and less able to respond effectively to young people with multiple disadvantages compared to community-based interventions [6,7].
In a recent paper in Drug and Alcohol Review, ‘Time to reconsider the best practice models of substance use care for young people’ [8], my colleagues and I put forward several strategies to enhance the benefits young people can gain from engagement with AOD services. These include:
- Addressing socio-structural determinants of health;
- Youth-friendly, flexible treatment services and proactive engagement with young people;
- Improving the culture of existing mainstream services;
- Addressing service gaps and improved access to evidence-based treatment;
- Better service linkage and active collaborative care models;
- Integrated, local services and community-based approaches; and
- Preventative care and harm reduction services for young people.
Young people benefit from a flexible and holistic treatment system able to account for the unique conditions of their lives. Taking account of and adapting to young people’s realities, priorities and circumstances increases the likelihood that the engagement will be beneficial, relevant and aligned with the meaning they themselves ascribe to their drug use. This involves broadening the range of treatment options to include offerings more aligned with the priorities and goals that young people have and promoting positive community connections and opportunities for meaningful and active participation. This involves seeing young people not as passive recipients of services, but as equal partners and active participants in a change process aimed more broadly at the flourishing of young people. Such an approach has capacity to minimise substance-related health, social and economic harms for young people, their families and communities.
Dr Maja Moensted
Discipline of Addiction Medicine, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
References
- Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2017-18: key findings. Australian Institute of Health and Welfare, Australian Government, Canberra; 2019. Available from: https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/aodts-2017-18-key-findings/contents/summary
- Fomiatti R, Farrugia A, Fraser S, Hocking S. Improving the effectiveness and inclusiveness of alcohol and other drug outreach models for young people: a literature review. Drugs Educ Prev Policy. 2023;30:105-14.
- Wilson M, Saggers S, Wildy H. Using narratives to understand progress in youth alcohol and other drug treatment. Qual Res J. 2013;13:114-31.
- Stockings E, Hall WD, Lynskey M, Morley KI, Reavley N, Strang J et al. Prevention, early intervention, harm reduction, and treatment of substance use in young people. Lancet Psychiatry. 2016;3:280-96.
- NSW Ministry of Health. Substance Use and Young People Framework. Centre for Alcohol and Other Drugs; 2014. Available from: https://www.health.nsw.gov.au/aod/professionals/Pages/substance-use-and-young-people-framework.aspx
- Gowan T, Whetstone S, Andic T. Addiction, agency, and the politics of self-control: Doing harm reduction in a heroin users’ group. Soc Sci Med. 2012;74:1251-60.
- van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL. Inequalities in healthcare provision for individuals with substance use disorders: perspectives from healthcare professionals and clients. J Subst Use. 2016;21:133-40.
- Moensted ML, Little S, Haber P, Day C. Time to reconsider the best practice models of substance use care for young people. Drug Alcohol Rev. 2024;43:817-22.
Full commentary is available Open Access
Moensted ML, Little S, Haber P, Day C. Time to reconsider the best practice models of substance use care for young people. Drug Alcohol Review. 2024;43:817-22. https://doi.org/10.1111/dar.13837